
100 Episódios De Podcast Cruzamento: E Agora? [PT]
Mar 4, 2025 - 15:11
Radio and PodcastLive Radio & Podcasts![86: Nuno Prego Ramos: Biotech Oncology Innovations [EN] artwork](https://www.cruzamentopodcast.com/wp-content/uploads/2024/06/NunoPregoRamos-1500-x-1500-px-2.jpg)
In today's episode of CRUZAMENTO Podcast, hosts André Correia and Daniel Guedelha sit down with biotech entrepreneur Nuno Prego Ramos to explore the intersection of technology and healthcare. Nuno shares insights into hi...
86: Nuno Prego Ramos: Biotech Oncology Innovations [EN] is an episode from Podcast Cruzamento by André Correia e Daniel Guedelha. In today's episode of CRUZAMENTO Podcast, hosts André Correia and Daniel Guedelha sit down with biotech entrep...
This episode belongs to Podcast Cruzamento.
Use the player on this page to stream the episode online.
Published Jul 2, 2024, 35:34 long, audio available.
In today's episode of CRUZAMENTO Podcast, hosts André Correia and Daniel Guedelha sit down with biotech entrepreneur Nuno Prego Ramos to explore the intersection of technology and healthcare. Nuno shares insights into his groundbreaking work at Cellmabs, a biotech company focusing on cancer-specific antigens, and its landmark deal with BioNTech. He also introduces Valvian, his new venture targeting age-related diseases and hard-to-treat tumours using AI-driven immunotherapies. Nuno discusses the importance of developing proprietary AI models for healthcare, the challenges of data privacy, and the necessity of curating high-quality data. The conversation highlights Portugal's potential as a biotech hub, emphasising the need for talent retention, ecosystem development, and international collaboration to drive innovation in the life sciences sector. Nuno Prego Ramos is the founder and CEO of Valvian , a Portuguese biotech company launched in January 2024 and announced at the East Coast Grand Investors Conference by Johnson & Johnson Innovation. With a law degree from the University of Lisbon further pursuing a Masters and Ph.D. in Biochemistry and immuno-oncology from Lisbon University, Nuno transitioned from a career in pharmaceuticals to focus on biotechnology. He founded CellmAbs in 2019, developing promising cancer therapies based on humanized monoclonal antibodies. Following the sale of these molecules to BioNTech in January 2024, he established Valvian, aiming to revolutionize cancer and longevity therapies through AI-driven research and to position Portugal as a global biotech leader. Contacts | Contactos: CruzamentoPodcast.com cruzamentopodcast@gmail.com LinkedIN: Cruzamento Twitter: @cruzamentofm Facebook: @podcastcruzamento Instagram: @cruzamentopodcast YouTube: Podcast Cruzamento Episode edited by João Cunha Studios
You can listen to 86: Nuno Prego Ramos: Biotech Oncology Innovations [EN] online on Radio and Podcast. Open the player on this page to stream the available audio.
86: Nuno Prego Ramos: Biotech Oncology Innovations [EN] is an episode from Podcast Cruzamento by André Correia e Daniel Guedelha.
This episode is 35:34 long.
This episode was published on Jul 2, 2024.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Podcast Cruzamento when more episodes are available from the podcast feed.
You can listen to 86: Nuno Prego Ramos: Biotech Oncology Innovations [EN] on this page when the episode audio is available from the podcast feed.
86: Nuno Prego Ramos: Biotech Oncology Innovations [EN] is from Podcast Cruzamento by André Correia e Daniel Guedelha.
Published Jul 2, 2024 and 35:34 long